3-bromo-4-methylcinnamic acid | 380607-14-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-bromo-4-methylcinnamic acid
• 英文别名: (2E)-3-(3-Bromo-4-methylphenyl)prop-2-enoic acid；(E)-3-(3-bromo-4-methylphenyl)prop-2-enoic acid
• CAS: 380607-14-7
• 化学式: C₁₀H₉BrO₂
• 分子量: 241.084
• InChiKey: GOUPQVNHVFDNJQ-SNAWJCMRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S,E)-ethyl 4-amino-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoate 、 3-bromo-4-methylcinnamic acid 在 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 (E)-(S)-4-[(E)-3-(3-Bromo-4-methyl-phenyl)-acryloylamino]-5-((S)-2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
  参考文献：
  名称：

  Structure-Based Design of a Parallel Synthetic Array Directed Toward the Discovery of Irreversible Inhibitors of Human Rhinovirus 3C Protease

  摘要：

  Utilizing the tools of parallel synthesis and structure-based design, a new class of Michael acceptor-containing, irreversible inhibitors of human rhinovirus 3C protease (HRV 3CP) was discovered. These inhibitors are shown to inhibit HRV-14 3CP with rates of inactivation ranging from 886 to 31400 M-1 sec(-1). These inhibitors exhibit antiviral activity when tested against HRV-14 infected H1-HeLa cells, with EC50 values ranging from 1.94 to 0.15 muM. No cytotoxicity was observed at the limits of the assay concentration. A crystal structure of one of the more potent inhibitors covalently bound to HRV-2 3CP is detailed, These compounds were also tested against HRV serotypes other than type 14 and were found to have highly variable activities.

  DOI：

  10.1021/jm010435c
• 作为产物：
  描述：

  3-溴-4-甲基苯甲醛 、 丙二酸 、 吡啶 生成 3-bromo-4-methylcinnamic acid
  参考文献：
  名称：

  BADDAR F. G.; MOUSSA G. E. M.; OMAR M. T., J. INDIAN CHEM. SOC. , 1976, 53, NO 10, 1053-1058

  摘要：

  DOI：

文献信息

• Propionic Acid Derivatives and Methods of Use Thereof
  申请人：Biediger Ronald J.

  公开号：US20180312523A1

  公开（公告）日：2018-11-01

  Provided herein are compounds and pharmaceutical compositions of formula I where R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.

  本文提供了公式I的化合物和药物组合物，其中R1、R2、R3、R4、R5和R6如本文所述。还提供了这些化合物的药用可接受盐或立体异构体。此外，还提供了用于抑制整合素结合以治疗各种病理生理条件的方法。
• Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
  申请人：——

  公开号：US20020061916A1

  公开（公告）日：2002-05-23

  Compounds of the formula: 1 where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.

  公式为1的化合物，其中公式变量如披露所定义，有利地抑制或阻断了小肠病毒3C蛋白酶的生物活性。这些化合物以及含有这些化合物的制药组合物，对于治疗感染了一个或多个小肠病毒（如RVP）的患者或宿主是有用的。还描述了制备这些化合物的中间体和合成方法。
• 1,2,3,4-TETRAHYDRO-1,1,4,4-TETRAMETHYLNAPHTHALENE DERIVATIVES USEFUL AS RXR MODULATORS FOR TREATING ALZHEIMER'S DISEASE AND CANCER
  申请人：Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University

  公开号：EP2910549A1

  公开（公告）日：2015-08-26

  The invention provides compounds of formula II: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.

  本发明提供了式 II 的化合物： 及其盐类，以及包含此类化合物的药物组合物。这些化合物可用于治疗癌症和阿尔茨海默病。
• Therapeutic compounds
  申请人：Arizona Board of Regents, A Body Corporate of the State of Arizona, Acting For and On Behalf of Arizona State University

  公开号：US10391093B2

  公开（公告）日：2019-08-27

  The invention provides compounds of formulae I, II, III, and IV: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers and Alzheimer's disease.

  本发明提供了式 I、II、III 和 IV 的化合物： 及其盐类，以及包含此类化合物的药物组合物。这些化合物可用于治疗癌症和阿尔茨海默病。
• Fluorescent synthetic retinoids
  申请人：High Force Research Limited

  公开号：US10759762B2

  公开（公告）日：2020-09-01

  There are described novel compounds of formula I: which R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each as herein defined.

  描述了式 I 的新型化合物：其中 R1、R2、R3、R4、R5、R6、R7、R8、R9 和 R10 各如本文所定义。